DRKS00022386Completed未知
Rumination: Mechanism of the antidepressant effect of exercise? Development of a decoder for the prediction of rumination during exercise
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Completed
- Enrollment
- 6
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
- Allocation
- Randomized controlled study
- Masking
- Blinded (masking used)
Eligibility Criteria
- Ages
- 18 Years to 40 Years (—)
- Sex
- All
Inclusion Criteria
- •informed, written consent;
- •currently diagnosed moderate depression diagnosed with SKID-V (F32.1-F32.1, F33.1-F33.2);
- •BDI-II Score > 20;
- •Age between 18-40 years;
- •fluent german skills;
- •no psychopharmacological treatment;
- •waiting period for ambulant psychotherapy > 2 months
Exclusion Criteria
- •acute suicidality;
- •schizophrenia and other psychotic disorders (F23, F20.81, F20.9 DSM-V);
- •acute substance misuse except for tabacco (F10, F11, F12, F13, F14, F15, F16, F18, F19 DSM-V);
- •current psychotherapy or start during the study period;
- •current psychopharmacological treatment or start during study period;
- •regular exercise (more then once a week for 30 minutes at a time endurance orientated exercise; e.g. jogging, cycling, swimming);
- •acute or chronic diseases influencing brain metabolism:
- •diabetes mellitus (E10-E14 ICD-10),
- •kidney insufficiency from stadium 3 of the kidney disease outcome quality initative,
- •non-adjusted hypertension (I10.x ICD-10), moderate to severe craniocerebral trauma (GSC 3-12) or rather craniocerebral trauma second or third degree with loss of concouisness for more than 30 minutes;
- •medical contraindications for exercise:
- •acute infectious diseases, medication intake, which in the opinion of the study physician do not permit an inclusion,
- •allergic diseases in an acute episode,
- •severe metabolic diseases,
- •non-adjusted hypertension,
- •cardiovascular diseases,
- •orthopedic symptoms, which in the opinion of the study physician do not permit an inclusion
Investigators
Similar Trials
Completed
Not Applicable
Fast Antidepressant Efficacy and Central Mechanisms of Single Low-Dose Ketamine Injection in Treating Major Depression: a double-blind and randomized-controlled trial and image studyJPRN-UMIN000016985Ministry of Science and Technology72
Recruiting
Not Applicable
Effect of mirtazapine and sertraline on BDI score and their link with serotonin transporter gene polymorphism in patients of Major depressive disorders .CTRI/2018/08/015172niversity College of Medical Sciences
Completed
Not Applicable
Antidepressant efficacy and mechanism of add-on cognitive activation to repetitive transcranial magnetic stimulation in depressioA randomized sham-controlled studyJPRN-UMIN000008421Taipei Veterans General Hospital36
Completed
Not Applicable
Investigating predictors of response to Transcranial Magnetic Stimulation for the treatment of depressioACTRN12610001071011Professor Paul Fitzgerald120
Active, not recruiting
Phase 1
Chronos: Can the antidepressive response induced by sleep deprivation (wake-therapy) be sustained through continuous stabilisation of the diurnal rhythm and long term light treatment in patients with major depression treated with duloxetine? - ChronosMajor depressionEUCTR2005-001855-39-DKPsychiatric Research Unit, Frederiksborg General Hospital100